Roy Bannister

机构：Gilead Sciences (United States) · ORCID：0000-0002-6311-1440

发表论文 53 篇 · 总被引 5531 次 · h-index 22

代表论文

• Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses (2017 · Science Translational Medicine · 被引 1639)
• Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge (2019 · Science Translational Medicine · 被引 278)
• Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in mice (2022 · Science Translational Medicine · 被引 83)
• Remdesivir (GS-5734) Is Efficacious in Cynomolgus Macaques Infected With Marburg Virus (2020 · The Journal of Infectious Diseases · 被引 82)
• Off-Target In Vitro Profiling Demonstrates that Remdesivir Is a Highly Selective Antiviral Agent (2020 · Antimicrobial Agents and Chemotherapy · 被引 57)
• Inhaled remdesivir reduces viral burden in a nonhuman primate model of SARS-CoV-2 infection (2021 · Science Translational Medicine · 被引 42)